中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
8期
3-4,5
,共3页
不稳定型心绞痛%同型半胱氨酸%N末端B型钠尿肽原
不穩定型心絞痛%同型半胱氨痠%N末耑B型鈉尿肽原
불은정형심교통%동형반광안산%N말단B형납뇨태원
UAP%HCY%NT-proBNP
目的：通过观察不稳定型心绞痛(UAP)患者治疗前后血清同型半胱氨酸(HCY)和N末端B型钠尿肽原(NT-proBNP)水平变化,探讨检测血清HCY和NT-proBNP的临床价值。方法选择60例UAP患者,检测治疗前后血清HCY和NT-proBNP水平,观察临床疗效。结果治疗前血清HCY和NT-proBNP水平均显著高于对照组(P<0.01)。治疗12周后,血清HCY和NT-proBNP水平均显著低于治疗前(P<0.01),治疗后的总有效率为85.0%(51/60),临床疗效显著。结论 UAP患者存在高水平的HCY和NT-proBNP,随着临床症状的改善,其水平显著下降,联合检测其水平可监测病情及指导治疗。
目的：通過觀察不穩定型心絞痛(UAP)患者治療前後血清同型半胱氨痠(HCY)和N末耑B型鈉尿肽原(NT-proBNP)水平變化,探討檢測血清HCY和NT-proBNP的臨床價值。方法選擇60例UAP患者,檢測治療前後血清HCY和NT-proBNP水平,觀察臨床療效。結果治療前血清HCY和NT-proBNP水平均顯著高于對照組(P<0.01)。治療12週後,血清HCY和NT-proBNP水平均顯著低于治療前(P<0.01),治療後的總有效率為85.0%(51/60),臨床療效顯著。結論 UAP患者存在高水平的HCY和NT-proBNP,隨著臨床癥狀的改善,其水平顯著下降,聯閤檢測其水平可鑑測病情及指導治療。
목적：통과관찰불은정형심교통(UAP)환자치료전후혈청동형반광안산(HCY)화N말단B형납뇨태원(NT-proBNP)수평변화,탐토검측혈청HCY화NT-proBNP적림상개치。방법선택60례UAP환자,검측치료전후혈청HCY화NT-proBNP수평,관찰림상료효。결과치료전혈청HCY화NT-proBNP수평균현저고우대조조(P<0.01)。치료12주후,혈청HCY화NT-proBNP수평균현저저우치료전(P<0.01),치료후적총유효솔위85.0%(51/60),림상료효현저。결론 UAP환자존재고수평적HCY화NT-proBNP,수착림상증상적개선,기수평현저하강,연합검측기수평가감측병정급지도치료。
Objective To discuss the clinical value of serum HCY and NT-proBNP by observing the UAP patients before and after treatment serum HCY and NT-proBNP level change. Methods Selecting 60 patients with UAP, test before and after treatment serum HCY and the NT-proBNP level, and observe the clinical curative effect. Results Serum HCY and the NT-proBNP level before treatment were significantly higher than that of control group (P<0.01). 12 weeks after treatment, serum HCY and the NT-proBNP levels were significantly lower than before treatment (P<0.01), after treatment the total effective rate was 85.0%(51/60), the clinical curative effect was distinct. Conclusion Patients with UAP have a high level of HCY and NT-proBNP, as to improve the clinical symptoms are significantly decreased, joint detection the level of monitoring condition can guide the treatment.
